Valuation: Sanofi

Capitalization 114B 119B 106B 93.88B 169B 10,120B 187B 1,310B 486B 4,160B 448B 438B 18,152B P/E ratio 2024 *
16.6x
P/E ratio 2025 * 12.1x
Enterprise value 120B 126B 112B 99.38B 179B 10,713B 198B 1,387B 514B 4,404B 474B 464B 19,215B EV / Sales 2024 *
2.62x
EV / Sales 2025 * 2.38x
Free-Float
87.09%
Yield 2024 *
4.26%
Yield 2025 * 4.47%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.66%
1 week-0.72%
Current month-1.52%
1 month-5.25%
3 months-13.27%
6 months+0.89%
Current year+1.04%
More quotes
1 week
90.34
Extreme 90.34
92.37
1 month
90.17
Extreme 90.17
94.83
Current year
84.93
Extreme 84.93
106.14
1 year
84.93
Extreme 84.93
106.14
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Director TitleAgeSince
Chief Executive Officer 57 31/08/2019
Director of Finance/CFO 62 31/03/2024
Chief Tech/Sci/R&D Officer 47 -
Manager TitleAgeSince
Director/Board Member 62 02/05/2013
Director/Board Member 71 30/04/2014
Director/Board Member 59 29/04/2019
More insiders
Name Weight AuM 1st Jan change Investor Rating
6.31% 5 M€ +4.56%
3.66% 128 M€ +9.94%
More ETFs: Sanofi
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.66%-0.72%+3.29%+4.81%120B
-1.72%-5.24%+33.79%+220.45%717B
-0.73%+0.58%+17.23%+108.92%492B
-0.27%-2.19%-5.69%-11.63%353B
-0.68%-1.69%+13.02%+38.03%308B
+1.50%-2.22%-2.98%+39.42%252B
-0.16%+0.71%+0.47%-32.23%232B
+0.28%+0.84%+4.68%+28.99%208B
+0.14%-2.26%+2.90%+17.95%199B
+0.24%-0.10%+0.03%+29.95%147B
Average -0.04%-1.37%+6.67%+44.47% 302.86B
Weighted average by Cap. -0.04%-1.81%+11.89%+78.00%
See all sector performances

Financials

2024 *2025 *
Net sales 45.94B 48.19B 42.81B 37.94B 68.36B 4,090B 75.5B 529B 196B 1,681B 181B 177B 7,336B 48.92B 51.31B 45.58B 40.4B 72.79B 4,355B 80.39B 564B 209B 1,790B 193B 188B 7,811B
Net income 6.94B 7.28B 6.46B 5.73B 10.32B 618B 11.4B 79.93B 29.63B 254B 27.34B 26.73B 1,108B 9.83B 10.31B 9.16B 8.12B 14.63B 875B 16.16B 113B 42B 360B 38.76B 37.88B 1,570B
Net Debt 6.66B 6.98B 6.2B 5.5B 9.91B 593B 10.94B 76.72B 28.44B 244B 26.25B 25.65B 1,063B 2.76B 2.89B 2.57B 2.28B 4.1B 245B 4.53B 31.76B 11.77B 101B 10.86B 10.62B 440B
More financial data * Estimated data
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Employees
86,088
Calendar
More about the company
Date Price Change Volume
12/12/24 90.69 -0.66% 1,556,573
11/12/24 91.29 -0.50% 1,246,198
10/12/24 91.75 -0.08% 1,455,141
09/12/24 91.82 -0.39% 1,250,170
06/12/24 92.18 +0.41% 1,419,655

Real-time Euronext Paris, December 12, 2024 at 04:36 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart SANOFIMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
90.69EUR
Average target price
114.09EUR
Spread / Average Target
+25.80%
Consensus

Quarterly revenue - Rate of surprise